This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mylan Laboratories Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Mahesh Hublikar: Innovator in Pharmaceutical Chemistry
Introduction
Mahesh Hublikar is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug production. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Mahesh Hublikar holds a patent for a process for the production of Etravirine. This novel process involves the condensation of ethyl cyanoacetate with N-cyanophenylguanidine to obtain a compound that is further converted into Etravirine. The detailed steps include the formation of an —OH compound, the creation of a leaving group, and subsequent reactions that yield the final product. His patent represents a significant advancement in the synthesis of this important pharmaceutical compound, with 1 patent to his name.
Career Highlights
Hublikar is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to innovate and improve drug manufacturing processes. His contributions have been instrumental in enhancing the efficiency and effectiveness of pharmaceutical production.
Collaborations
Throughout his career, Mahesh has collaborated with talented professionals in the industry, including Vinayak Gore and Choudhari Bharati. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical chemistry.
Conclusion
Mahesh Hublikar's work exemplifies the vital role of inventors in advancing healthcare through innovative drug production methods. His patent for Etravirine highlights his commitment to improving pharmaceutical processes, making a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
